Healthcare

Telix operates through Precision Medicine and Telix Manufacturing Solutions (TMS), while advancing a separate portfolio of investigational cancer treatments. Its approved prostate cancer imaging products include Illuccix and Gozellix, which use prostate-specific membrane antigen targeting for positron emission tomography (PET). Pixclara is a U.S.-approved …

EBOS Group (ASX:EBO) reports through Healthcare and Animal Care segments, with four operating divisions. Symbion and Healthcare Distribution supplies pharmacies, hospitals and healthcare partners; Retail Pharmacy Brands provides branding, services and retail support to independent pharmacies. Medical Technology distributes specialist equipment, biologics and related …

Neuren Pharmaceuticals Limited develops treatments for serious neurological conditions associated with genetic disorders and brain injury, including therapies for Rett syndrome and Phelan-McDermid syndrome. The Melbourne-based biopharmaceutical company reported increased royalty receipts from licensed treatment DAYBUE while advancing its NNZ-2591 clinical program in 2026. …

The company develops treatments using its mesenchymal lineage cell technology platforms. Ryoncil (remestemcel-L-rknd) is approved in the United States for steroid-refractory acute graft-versus-host disease in paediatric patients aged two months and older. This condition can arise following stem-cell transplantation and is treated in specialist …

The Melbourne-based medical technology group supplies imaging analytics to hospitals, radiology providers and healthcare partners. Its products include XV LVAS, which measures regional ventilation using X-ray imaging, CT LVAS, which analyses lung function from CT scans, and CT:VQ, which estimates ventilation and perfusion using …

PYC Therapeutics (ASX:PYC) designs RNA therapies intended to influence production of proteins affected by specific genetic variants. Its approach links therapeutic oligonucleotides to cell-penetrating peptides, seeking to improve delivery inside cells. This platform is being studied in renal, ocular and neurological disorders. The organisation …

Ryman develops, owns and operates retirement villages that combine accommodation and services with access to higher levels of care as residents’ needs change. Its retirement living offering includes independent units and serviced apartments; its aged care operations provide residential care across its New Zealand …